Feline Sporotrichosis Caused by Sporothrix Schenckii Sensu Stricto in Southern Thailand: Phenotypic Characterization, Molecular Identification, and Antifungal Susceptibility
Overview
Veterinary Medicine
Authors
Affiliations
Feline sporotrichosis caused by the Sporothrix schenckii complex is a global subcutaneous mycosis, having higher prevalence in Latin America and Malaysia. However, its etiological agents have not been elucidated in Thailand, a neighboring country of Malaysia, where the cases are increasing. This study identified 38 feline isolates of S. schenckii from Southern Thailand, collected between 2018 and 2021, using phenotypic characterization and molecular identification using polymerase chain reaction (PCR)-sequencing of partial calmodulin (CAL) and ß-tubulin (Bt2) genes. Phenotypic characteristics proved that the isolates were S. schenckii sensu lato, with low thermotolerance. Based on partial CAL and Bt2-PCR sequencing, all isolates were identified as S. schenckii sensu stricto. Phylogenetic analyses revealed that the isolates were clustered with S. schenckii sensu stricto isolated from the cats in Malaysia. A low degree of genetic diversity was observed among the Thai feline isolates. The antifungal susceptibility of these isolates to antifungal agents, including itraconazole (ITC), ketoconazole (KTC), fluconazole (FLC), and amphotericin B (AMB), was investigated according to the M27-A3 protocol of the Clinical and Laboratory Standards Institute. Results showed low ITC, KTC, and AMB activities against S. schenckii sensu stricto isolates, with high minimum inhibitory concentration (MIC) ranges of 1-8, 1-8, and 2-16 μg/ml, respectively, whereas FLC exhibited MICs of 64 and > 64 μg/ml. This study indicated that S. schenckii sensu stricto is the causative agent responsible for feline sporotrichosis in Southern Thailand. Their phenotypic characteristics and in vitro antifungal susceptibility profiles will help to improve our understanding of this mycosis in Thailand.
Aroonvuthiphong V, Bangphoomi N Sci Rep. 2025; 15(1):3230.
PMID: 39863777 PMC: 11762301. DOI: 10.1038/s41598-025-87711-3.
Jirawattanadon P, Bunyaratavej S, Leeyaphan C, Chongtrakool P, Sitthinamsuwan P, Panjapakkul W Emerg Infect Dis. 2024; 30(12):2583-2592.
PMID: 39592393 PMC: 11616660. DOI: 10.3201/eid3012.240467.
Lopez L, Gade L, Litvintseva A, Sexton D Microbiol Spectr. 2024; :e0116224.
PMID: 39436137 PMC: 11619315. DOI: 10.1128/spectrum.01162-24.
Invasive fungal infections and oomycoses in cats 2. Antifungal therapy.
Barrs V, Hobi S, Wong A, Sandy J, Shubitz L, Beczkowski P J Feline Med Surg. 2024; 26(1):1098612X231220047.
PMID: 38189264 PMC: 10949877. DOI: 10.1177/1098612X231220047.
related to zoonotic transmission in Thailand.
Chieosilapatham P, Chuamanochan M, Chiewchavit S, Saikruatep R, Amornrungsun E, Preechasuth K Med Mycol Case Rep. 2023; 41:44-47.
PMID: 37706041 PMC: 10495378. DOI: 10.1016/j.mmcr.2023.08.003.